Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium chloride + calcium chloride + sodium lactate + dextrose monohydrate + potassium chloride** is a sterile intravenous crystalloid electrolyte and carbohydrate combination product corresponding to a potassium-containing dextrose lactated Ringer's solution. It is used as a parenteral source of water, electrolytes, and minimal calories, and as an alkalinizing agent for replacement of extracellular fluid and electrolyte losses in adults and pediatric patients. Its pharmacologic effect is not mediated through a single receptor target; instead, the solution restores extracellular fluid volume and electrolyte composition, potassium chloride supplements potassium, dextrose provides carbohydrate calories, and sodium lactate is metabolized to bicarbonate to help buffer metabolic acidosis. Public labeling and product information identify products of this exact composition as marketed intravenous infusion solutions from Hospira and ICU Medical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + calcium chloride + sodium lactate + dextrose monohydrate + potassium chloride.